BIOLIFE SOLUTIONS INC
For the period ended Dec 31, 2024. Filed Mar 3, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 3, 2025
BLFS$38.61+3.5%Stored close · as of Oct 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
| Years Ended December 31 | |||
|---|---|---|---|
| (In thousands) | 2024 | 2023 | 2022 |
| Net loss | $(20,184) | $(68,002) | $(139,805) |
| Other comprehensive (loss) income - foreign currency translation adjustment, net of tax | — | 278 | (347) |
| Unrealized (loss) gain on available-for-sale securities, net of tax | (18) | 56 | (50) |
| Comprehensive loss | $(20,202) | $(67,668) | $(140,202) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.